Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.

Pertl MM, Hevey D, Boyle NT, Hughes MM, Collier S, O'Dwyer AM, Harkin A, Kennedy MJ, Connor TJ.

Brain Behav Immun. 2013 Nov;34:108-19. doi: 10.1016/j.bbi.2013.07.177. Epub 2013 Aug 6.

PMID:
23928287
2.

Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.

Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ.

Brain Behav Immun. 2012 Aug;26(6):979-87. doi: 10.1016/j.bbi.2012.05.010. Epub 2012 Jun 6.

PMID:
22683764
3.

Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?

Quak J, Doornbos B, Roest AM, Duivis HE, Vogelzangs N, Nolen WA, Penninx BW, Kema IP, de Jonge P.

Psychoneuroendocrinology. 2014 Jul;45:202-10. doi: 10.1016/j.psyneuen.2014.03.013. Epub 2014 Apr 5.

PMID:
24845191
4.

Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.

Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD.

Brain Behav Immun. 2009 Aug;23(6):868-74. doi: 10.1016/j.bbi.2009.04.003. Epub 2009 Apr 9.

PMID:
19362138
5.

Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.

Raison CL, Lin JM, Reeves WC.

Brain Behav Immun. 2009 Mar;23(3):327-37. doi: 10.1016/j.bbi.2008.11.005. Epub 2008 Dec 11.

PMID:
19111923
6.

Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling.

Mackay GM, Forrest CM, Christofides J, Bridel MA, Mitchell S, Cowlard R, Stone TW, Darlington LG.

Clin Exp Pharmacol Physiol. 2009 Apr;36(4):425-35. doi: 10.1111/j.1440-1681.2008.05077.x. Epub 2008 Oct 31.

PMID:
19018805
7.

Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway.

Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H.

Brain Behav Immun. 2011 Oct;25(7):1376-83. doi: 10.1016/j.bbi.2011.04.001. Epub 2011 Apr 7.

PMID:
21496483
8.

Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke.

Ormstad H, Verkerk R, Amthor KF, Sandvik L.

J Mol Neurosci. 2014;54(2):181-7. doi: 10.1007/s12031-014-0272-0. Epub 2014 Mar 25.

PMID:
24664436
10.

Interferon gamma (IFN-γ)-mediated inflammation and the kynurenine pathway in relation to risk of hip fractures: the Hordaland Health Study.

Apalset EM, Gjesdal CG, Ueland PM, Øyen J, Meyer K, Midttun Ø, Eide GE, Tell GS.

Osteoporos Int. 2014 Aug;25(8):2067-75. doi: 10.1007/s00198-014-2720-7. Epub 2014 May 10.

11.

Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients.

Low CA, Bovbjerg DH, Jenkins FJ, Ahrendt SA, Choudry HA, Holtzman MP, Jones HL, Pingpank JF, Ramalingam L, Zeh HJ, Zureikat AH, Bartlett DL.

Brain Behav Immun. 2014 Nov;42:65-8. doi: 10.1016/j.bbi.2014.06.019. Epub 2014 Jul 6.

12.

Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors.

Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R.

J Psychosom Res. 2011 Sep;71(3):136-41. doi: 10.1016/j.jpsychores.2011.04.003. Epub 2011 May 18.

PMID:
21843747
13.

Kynurenines in cognitive functions: their possible role in depression.

Plangar I, Majlath Z, Vecsei L.

Neuropsychopharmacol Hung. 2012 Dec;14(4):239-44. Review.

14.
15.

Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.

Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S.

Brain Behav Immun. 2012 Jul;26(5):706-13. doi: 10.1016/j.bbi.2012.02.001. Epub 2012 Mar 2.

16.

Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?

Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW.

J Clin Oncol. 2011 Sep 10;29(26):3517-22. doi: 10.1200/JCO.2011.36.1154. Epub 2011 Aug 8.

17.

Acute phase protein and cytokine levels in serum and saliva: a comparison of detectable levels and correlations in a depressed and healthy adolescent sample.

Byrne ML, O'Brien-Simpson NM, Reynolds EC, Walsh KA, Laughton K, Waloszek JM, Woods MJ, Trinder J, Allen NB.

Brain Behav Immun. 2013 Nov;34:164-75. doi: 10.1016/j.bbi.2013.08.010. Epub 2013 Aug 31.

PMID:
23999491
18.
19.

Interrelationship of depression, stress and inflammation in cancer patients: a preliminary study.

Archer JA, Hutchison IL, Dorudi S, Stansfeld SA, Korszun A.

J Affect Disord. 2012 Dec 20;143(1-3):39-46. doi: 10.1016/j.jad.2012.05.023. Epub 2012 Jul 30.

PMID:
22854100
20.

Supplemental Content

Support Center